A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...

A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...

In solid tumors, such as skin, lung, or bone and soft tissue cancer ... New Immune Boost Could Expand Access to Cancer Immunotherapy Apr. 11, 2025 — Researchers have found that tapping into the ...

Electronic nose breath analysis achieved 80-92% accuracy for detecting lung cancer in patients with suspicious findings. Detection accuracy remained consistent across tumor characteristics ...

A super-fit father who never smoked in his life was diagnosed with terminal lung cancer. In 2022, Chad Dunbar received the shock diagnosis of lung cancer a week after he had logged over 3,000 miles ...

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2-mutant non-small cell lung cancer ... and highly active TKIs hot ...

She was repeatedly tested for COVID-19 and treated for seasonal allergies, asthma, and acute pneumonia before finally learning she had a tumor in her left lung. “I found out I had cancer right around ...

“The AI-enabled CXRs revealed important findings, including lung nodules at high risk for cancer in nearly 50,000 people – prompting their referral for further testing and possible diagnosis ...

Results showed tarlatamab demonstrated statistically significant and clinically meaningful improvement in overall survival vs standard of care therapy. Topline data were announced from a phase 3 ...

At this year’s American Association for Cancer Research (AACR) Annual Meeting in Chicago, the German drugmaker added durability and progression free survival (PFS) results to the breadth of data ...